1. Diven DG: An overview of poxviruses. J Am Acad Dermatol 44(1):1-16, 2001
2. Fenner F et al: Smallpox and Its Eradication. Geneva, Switzerland, World Health Organization, 1988
3. Huq F: Effect of temperature and relative humidity on variola virus in crusts. Bull World Health Organ 54:710-712, 1976
4. Breman JG, Henderson DA: Diagnosis and management of smallpox. N Engl J Med 346(17):1300-1308, 2002
5. Kiang KM, Krathwohl MD: Rates and risks of transmission of smallpox and mechanisms of prevention. J Lab Clin Med 142(4):229-238, 2003
6. Henderson DA et al: Smallpox as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense. JAMA 281(22):2127-2137, 1999
7. Cohen J: Bioterrorism. Smallpox vaccinations: How much protection remains? Science 294:985, 2001
8. Slifka MK, Hanifin JM: Smallpox: The basics. Dermatol Clin 22(3):263-274, 2004
9. McFadden G: Killing a killer: What next for smallpox? Pub Lib Sci Pathog 29(6):e1000727, 2010
10. Lupatkin H, Lupatkin JF, Rosenberg AD: Smallpox in the 21st century. Anesthesiol Clin North America 22(3):541-561, 2004
11. Moore ZS, Seward JF, Lane JM: Smallpox. Lancet 367:425-435, 2006
12. Fulginiti
VA et al: Smallpox vaccination: A review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions.
Clin Infect Dis 37(2):241-250, 2003
13. Guharoy R et al: Smallpox: Clinical features, prevention, and management. Ann Pharmacother 38(3):440-447, 2004
14. Rao AR: Smallpox. Bombay, India, Kothari Book Depot, 1972
15. Nafziger SD: Smallpox. Crit Care Clin 21(4):739-746, 2005
16. McKenzie PJ et al: Haemorrhagic smallpox. Bull World Health Organ 33:773-782, 1965
17. Arora A, Agarwal A, Kumar S: Osteomyelitis variolosa: A report of two cases. J Orthop Surg (Hong Kong) 16(3):355-358, 2008
18. Fenner F, Wittek R, Dumbell KR: The Orthopoxviruses. San Diego, Academic Press, 1989
19. Ropp SL et al: PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J Clin Microbiol 33(8):2069-2076, 1995
20. Kern ER: In vitro activity of potential anti-poxvirus agents. Antiviral Res 57:35-40, 2003
21. Parker S et al: Efficacy of therapeutic intervention with an oral ether-lipid analogue of
cidofovir (CMX001) in a lethal mousepox model.
Antiviral Res 77(1):39-49, 2008
22. Jordan R et al: ST-246 antiviral efficacy in a nonhuman primate monkeypox model: Determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother 53(5):1817-1822 2009 Epub 2009 Feb 17.
23. Dixon CW: Smallpox. London, England: J&A Churchill Ltd, 1962
24. Poland GA, Neff JM: Smallpox vaccine: Problems and prospects. Immunol Allergy Clin North Am 23(4):731-743, 2003
25. Centers for Disease Control and Prevention: Laboratory-acquired vaccinia virus infection—Virginia, 2008. MMWR 58(29):797-800, 2009
26. Belongia EA, Naleway AL: Smallpox vaccine: The good, the bad, and the ugly. Clin Med Res 1(2):87-92, 2003
27. Center for Disease Control and Prevention: Notice to readers: Newly licensed smallpox vaccine to replace old smallpox vaccine. MMWR 57(8):207-208, 2008
28. Greenberg RN, Kennedy JS: ACAM2000: A newly licensed cell culture-based live vaccinia smallpox vaccine. Expert Opin Investig Drugs 17(4):555-564, 2008
29. Handley L et al: The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks. Expert Rev Vaccines 8(7):841-850, 2009
31. Frey SE et al: Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 346(17):1265-1274, 2002
32. Cono J, Casey CG, Bell DM: Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep 52:1-28, 2003
33. Centers for Disease Control and Prevention: Vaccinia (smallpox) vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 50:1-25, 2001
34. Fulginiti
VA et al: Smallpox vaccination: A review, part II. Adverse events.
Clin Infect Dis 37(2):251-271, 2003
35. Neff JM et al: Contact vaccinia—transmission of vaccinia from smallpox vaccination. JAMA 288:1901-1905, 2002
36. Cleri DJ, Villota FJ, Porwancher RB: Smallpox, bioterrorism, and the neurologist. Arch Neurol 60:489-494, 2003
37. Bartlett J et al: Smallpox vaccination in 2003: Key information for clinicians. Clin Infect Dis 36:883-902, 2003
38. Halsell JS et al: Myopericarditis following smallpox vaccination among vaccinia-naïve US military personnel. JAMA 289:3283-3289, 2003
39. Moyron-Quiroz JE et al: The smallpox vaccine induces an early neutralizing IgM response. Vaccine 10(28):140-147, 2009
40. Tom WL, Kenner JR, Friedlander SF: Smallpox: Vaccine reactions and contraindications. Dermatol Clin 22(3):275-289, 2004
41. Centers for Disease Control and Prevention: Update. Cardiac-related events during the civilian smallpox vaccination program—United States, 2003. MMWR 52:492-496, 2003
42. Centers for Disease Control and Prevention: Progressive vaccinia in a military smallpox vaccinee—United States, 2009. MMWR 58(19):532-536, 2009
43. Maurer DM, Harrington B, Lane JM: Smallpox vaccine: Contraindications, administration, and adverse reactions. Am Fam Physician 68(5):889-896, 2003
44. Schwartz B, Lebwohl M: Complications of the smallpox vaccine. Int J Dermatol 44(4):289-292, 2005
45. von Krempelhuber A et al: A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE. Vaccine 28(5):1209-1216, 2010
46. Bonilla-Guerrero B, Poland GA: Smallpox vaccines: Current and future. J Lab Clin Med 142:252-257, 2003
47. Nalca A et al: Reemergence of monkeypox: Prevalence, diagnostics, and countermeasures. Clin Infect Dis 41(12):1765-1771, 2005
48. Ligon BL: Monkeypox: A review of the history and emergence in the Western hemisphere. Semin Pediatr Infect Dis 15(4):280-287, 2004
49. Reed KD et al: The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 350(4):342-350, 2004
50. Di Giulio DB, Eckburg PB: Human monkeypox: An emerging zoonosis. Lancet Infect Dis 4(1):15-25, 2004
51. Cho CT, Wenner HA: Monkeypox virus. Bacteriol Rev 37(1):1-18, 1973
52. Weaver JR, Isaacs SN: Monkeypox virus and insights into its immunomodulatory proteins. Immunol Rev 225:96-113, 2008
53. Pattyn SR: Monkeypoxvirus infections. Rev Sci Tech 19(1):92-97, 2000
54. Breman JG: Monkeypox: An emerging infection for humans? In: Emerging Infections, 4th edition, edited by WM Scheld, WA Craig, JM Hughes. Washington DC, ASM Press, 2000
55. Huhn GD et al: Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 41(12):1742-1751, 2005
56. Centers for Disease Control and Prevention: Update: Multistate outbreak of monkeypox–Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR 52(27):642-646, 2003
57. Marriott KA, Parkinson CV, Morefield SI: Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine 24(26):581-588, 2008
58. Barraviera SR: Diseases caused by poxvirus—orf and milker's nodules: A review. J Venom Anim Toxins incl Trop Dis 11(2):102-108, 2005
59. Werchniak AE et al: Milker's nodule in a healthy young woman. J Am Acad Dermatol 49(5):910-911, 2003
60. Schuler G, Honigsmann H, Wolff K: The syndrome of milker's nodules in burn injury: Evidence for indirect viral transmission. J Am Acad Dermatol 6(3):334-339, 1982
61. Lewis-Jones S: The zoonotic poxviruses. Dermatol Nurs 14(2):79-82, 85-86, 2002
62. Groves RW, Wilson-Jones E, MacDonald DM: Human orf and milker's nodule: A clinicopathologic study. J Am Acad Dermatol 25:2813-2818, 1961
63. Lewis-Jones S: Zoonotic poxvirus infections in humans. Curr Opin Infect Dis 17(2):81-89, 2004
64. Shelley WB, Shelley ED: Farmyard pox: Parapox virus infection in man. Br J Dermatol 108(6):725-727, 1983
65. Shelley WD, Shelley ED: Surgical treatment of farmyard pox: Orf, milker's nodule, bovine pustular stomatites pox. Cutis 31:256-257, 1983
66. Shelukhina EM et al: Clustered cases of paravaccinia in milkers. J Hyg Epidemiol Microbiol Immunol 30(4):411-417, 1986
67. Mercer A et al: Molecular genetic analyses of parapoxviruses pathogenic for humans. Arch Virol Supp 13:25-34, 1997
68. Centers for Disease Control and Prevention: Orf virus infection in humans—New York, Illinois, California and Tennessee, 2004–2005. MMWR 55(03):65-68, 2006
69. Cottone R et al: Analysis of genomic rearrangement and subsequent gene deletion of the attenuated orf virus strain D1707. Virus Res 56(1):53-67, 1998
70. Gurel MS et al: Giant orf on the nose. Eur J Dermatol 12(2):183-185, 2002
71. Mourtada I et al: Human orf and erythema multiforme. Ann Dermatol Venereol 127(4):397-339, 2000
72. Dupre A et al: Orf and atopic dermatitis. Br J Dermatol 105(1):103-104, 1981
73. Macfarlane AW: Human orf complicated by bullous pemphigoid. Br J Dermatol 137(4):656-657, 1997
74. Geernick K et al: A case of human orf in an immunocompromised patient treated successfully with
cidofovir cream.
J Med Virol 64:54-59, 2001
75. Becker TM et al: Trends in molluscum contagiosum in the US, 1966–1983. Sex Transm Dis 13(2):88-92, 1986
76. Dohil MA et al: The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol 54:47-54, 2006
77. Nizeki K, Kano O, Yoshiro K: An epidemic study of molluscum contagiosum: Relationship to swimming. Dermatologica 169:197-198, 1984
78. Choong KY, Roberts LJ: Molluscum contagiosum, swimming and bathing: A clinical analysis. Australas J Dermatol 40:89-92, 1999
79. Luke JD, Silverberg NB: Vertically transmitted molluscum contagiosum infection. Pediatrics 125(2):e423-e425, 2010
80. Senkevich TG et al: The genome of molluscum contagiosum virus: Analysis and comparison with other poxviruses. Virology 233(1):19-42, 1997
81. Smith K, Yeager J, Skelton H: Molluscum contagiosum: Its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol 38:664-672, 1999
82. Buggert JJ, Darai G: Recent advances in molluscum contagiosum virus research. Arch Virol Suppl 13:35-47, 1997
83. Moss B et al: Immune-defense molecules of molluscum contagiosum virus, a human poxvirus. Trends Microbiol 8(10):473-477, 2000
84. Gur I: The epidemiology of molluscum contagiosum in HIV-seropositive patients: A unique entity or insignificant finding? Int J STD AIDS 19(8):503-506, 2008
85. Dohil MA, Prendiville JS: Treatment of molluscum contagiosum with oral
cimetidine: Clinical experience in 13 patients.
Pediatr Dermatol 13(4):310-312, 1996
86. van der Wouden JC et al: Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev 4:CD004767, 2009